(Q52314493)

29 April 2018

title

Argatroban During Percutaneous Transluminal Coronary Angioplasty: Results of a Dose-Verification Study. (English)

1 reference

29 April 2018

1 reference

6

Serruys PW

1 reference

29 April 2018

Harry Suryapranata

2

object named as

Suryapranata H

1 reference

29 April 2018

author name string

Herrman JP

1

1 reference

29 April 2018

den Heijer P

3

1 reference

29 April 2018

Gabriël L

4

1 reference

29 April 2018

Kutryk MJ

5

1 reference

29 April 2018

publication date

1 January 1996

1 reference

29 April 2018

Journal of Thrombosis and Thrombolysis

published in

1 reference

29 April 2018

volume

3

1 reference

29 April 2018

issue

4

1 reference

29 April 2018

page(s)

367-375

1 reference

29 April 2018

https://scigraph.springernature.com/pub.10.1007/bf00133080

exact match

0 references

cites work

Effect of argatroban on thrombus formation during acute coronary occlusion after balloon angioplasty.

1 reference

12 December 2020

Experimental evaluation of coronary thrombodynamics and effects of pharmacological interventions in acute coronary syndromes

1 reference

12 December 2020

Choice of anticoagulant in a congenital antithrombin III (AT III)-deficient patient with chronic renal failure undergoing regular haemodialysis

1 reference

12 December 2020

Importance of antithrombin therapy during coronary angioplasty

1 reference

12 December 2020

Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?

1 reference

12 December 2020

Combined administration of aspirin and a specific thrombin inhibitor in man

1 reference

12 December 2020

Unstable angina. A classification

1 reference

12 December 2020

Anticoagulant therapy with MD805 of a hemodialysis patient with heparin-induced thrombocytopenia

1 reference

12 December 2020

The reliability of Hickman catheter blood for the assessment of activation markers of coagulation and fibrinolysis in patients with hematological malignancies

1 reference

12 December 2020

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

1 reference

12 December 2020

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

12 December 2020

Heparin and the thrombin inhibitor argatroban enhance fibrinolysis by infused or bolus-injected saruplase (r-scu-PA) in rabbit femoral artery thrombosis

1 reference

12 December 2020

Development of nonthrombogenicity of injured rabbit aortas despite inhibition of platelet adherence

1 reference

12 December 2020

Clinical Application of the Synthetic Thrombin Inhibitor, Argatroban (MD-805)

1 reference

12 December 2020

Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis

1 reference

12 December 2020

Use of a direct thrombin inhibitor (argatroban) during pulse-spray thrombolysis in experimental thrombosis

1 reference

12 December 2020

Persistent thrombin generation in humans during specific thrombin inhibition with hirudin

1 reference

12 December 2020

Antithrombotic effect of argatroban on the pial vessels of the rat: a study with He-Ne laser-induced thrombus formation

1 reference

12 December 2020

Inhibitory effect of clopidogrel, vapiprost and argatroban on the middle cerebral artery thrombosis in the rat.

1 reference

12 December 2020

The electrocardiogram in population studies. A classification system

1 reference

12 December 2020

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty

1 reference

12 December 2020

Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model

1 reference

12 December 2020

Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin

1 reference

12 December 2020

Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty

1 reference

12 December 2020

Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

1 reference

12 December 2020

Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis

1 reference

12 December 2020

Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time

1 reference

12 December 2020

Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator

1 reference

12 December 2020

Platelet accumulation in experimental angioplasty: time course and relation to vascular injury

1 reference

12 December 2020

Enhancement of thrombolytic efficacy of tissue-type plasminogen activator by adjuvants in the guinea pig thrombosis model

1 reference

12 December 2020

The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels

1 reference

12 December 2020

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris

1 reference

12 December 2020

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

12 December 2020

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00133080

1 reference

29 April 2018

1 reference

29 April 2018